Pentwater Capital Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Pentwater Capital Management’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-35,000	Closed	-$1.18M	–	357
2021 Q2	$1.18M	Buy	+35,000	New	+$892K	0.01%	193

Pentwater Capital Management's CNST Position: Q3 2021 in Review

Pentwater Capital Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 35,000 shares — an estimated $1.18M sold.

Pentwater Capital Management first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $1.18M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Pentwater Capital Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Pentwater Capital Management sold 35,000 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $1.18M.
Pentwater Capital Management first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
Pentwater Capital Management's Constellation Pharmaceuticals, Inc. position peaked at $1.18M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Pentwater Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.